Agence Nationale de Sécurité du Médicament e des Produits de Santé (ANSM), France, conducted a Good Manufacturing Practices (GMP) inspection of Cenexi's Fontenay Manufacturing Facility (material subsidiary of Gland Pharma Limited) between December 9th to 19th, 2024.

The said inspection was concluded, and the facility received an official notification on December 24, 2024, citing 10 (TEN) observations. Cenexi is committed to working closely with the ANSM to address the observations.